Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea, Republic of Korea
Disclosure information not submitted.
Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes
Wednesday, August 28, 20242:15 PM – 2:30 PM CEST
